2 results
Approved WMOCompleted
To provide continued bevacizumab therapy as single agent or in combination with an anti-cancer drug to patients with cancer, who were previously enrolled in a F. Hoffmann-La Roche (Roche)/ Genentech sponsored bevacizumab study (i.e. the Parent, P-…
Approved WMOCompleted
To compare gait and balance measured by the traditional 3D gait analysis system (VICON) and by the new system including a treadmill and a virtual environment (CAREN) during self- paced walking in typically developed children. In addition, a…